Ticker symbol change effective at the market open
May 22, 2023
NEW
YORK, May 19, 2023 /PRNewswire/ -- Fresh2 Group
Ltd., formerly AnPac Bio-Medical Science Co., Ltd.
(NASDAQ: ANPC), a company with operations in the United
States and China focused on early cancer screening
and detection and plans to enter into the operation of a
business-to-business e-commerce food platform focused on the sale
of Asian sourced food products, today announced that its ticker
symbol on the Nasdaq Stock Market ("Nasdaq") will change to "FRES"
effective at the open of market trading on May 22, 2023
following the Company's name change from AnPac Bio-Medical
Science Co., Ltd to Fresh2 Group Ltd. The Company has traded under
the ticker "ANPC" since the Company's initial public offering in
2020.
Mr. Haohan Xu, Co-CEO of the
Company commented: "Transitioning to the ticker 'FRES' is the most
recent step we have taken toward our strategic initiative to focus
on the recently engaged new business line of business-to-business
food trade and delivery platform for U.S. local restaurants and
supermarkets. The ticker symbol change aligns with our new brand
identity in the U.S. food market and reflects our vision for the
future. We believe that we are well positioned to increase our
presence in the new business sector with scalable business model
and look forward to our future with confidence."
No action by the company's shareholders is required with respect
to the ticker symbol change. The company's CUSIP number will remain
unchanged.
About Fresh2 Group Limited
Fresh2 Group Limited is a biotechnology company focused on early
cancer screening and detection, with 155 issued patents as of
March 31, 2023. With two certified
clinical laboratories in China and
one CLIA and CAP accredited clinical laboratory in the United States, Fresh2 performs a suite of
cancer screening and detection tests, including CDA (Cancer
Differentiation Analysis), bio-chemical, immunological, and
genomics tests. The Company is entering the business-to-business
e-commerce food business with the formation of its wholly-owned
subsidiary Fresh2 Technology Inc and the acquisition of Fresh2
Ecommerce Inc.
For more information, please visit:
https://fresh2.co/investors.
For investor and media inquiries, please contact:
Ascent Investor Relations LLC
Tina Xiao
Phone: +1-917-609-0333 (U.S.)
Email: tina.xiao@ascent-ir.com
Safe Harbor Statement
This announcement contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934. These
forward-looking statements are made under the "safe harbor"
provisions of the Private Securities Litigation Reform Act of 1995
and are relating to the Company's future financial and operating
performance. The Company has attempted to identify forward-looking
statements by terminologies including "believes," "estimates,"
"anticipates," "expects," "plans," "projects," "intends,"
"potential," "target," "aim," "predict," "outlook," "seek," "goal"
"objective," "assume," "contemplate," "continue," "positioned,"
"forecast," "likely," "may," "could," "might," "will," "should,"
"approximately" or other words that convey uncertainty of future
events or outcomes to identify these forward-looking statements.
These statements are based on current expectations, assumptions and
uncertainties involving judgments about, among other things, future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond the Company's control.
These statements also involve known and unknown risks,
uncertainties and other factors that may cause the Company's actual
results to be materially different from those expressed or implied
by any forward-looking statement. Known and unknown risks,
uncertainties and other factors include, but are not limited to,
our ability to comply with Nasdaq Listing Rules including
maintaining our listing on the Nasdaq Capital Market, the
implementation of our business model and growth strategies; trends
and competition in the cancer screening and detection market; our
expectations regarding demand for and market acceptance of our
cancer screening and detection tests and our ability to expand our
customer base; our ability to obtain and maintain intellectual
property protections for our CDA technology and our continued
research and development to keep pace with technology developments;
our ability to obtain and maintain regulatory approvals from the
NMPA, the FDA and the relevant U.S. states and have our
laboratories certified or accredited by authorities including the
CLIA; our future business development, financial condition and
results of operations and our ability to obtain financing
cost-effectively; potential changes of government regulations;
general economic and business conditions in China and
elsewhere; our ability to hire and maintain key personnel; our
relationship with our major business partners and customers; and
the duration of the coronavirus outbreaks and their potential
adverse impact on the economic conditions and financial markets and
our business and financial performance, such as resulting from
reduced commercial activities due to quarantines and travel
restrictions instituted by China, the U.S. and many other
countries around the world to contain the spread of the virus. A
number of these risks along with additional discussion of
forward-looking statements, are set forth in the Company's Annual
Report on Form 20-F and other reports filed with the Securities and
Exchange Commission. In addition, there is uncertainty about the
spread of the COVID19 virus and the impact it will have on the
Company's operations, global supply chains and economic activity in
general. Because of these and other risks, uncertainties and
assumptions, undue reliance should not be placed on these
forward-looking statements. In addition, these statements speak
only as of the date of this press release and, except as may be
required by law, the Company undertakes no obligation to revise or
update publicly any forward-looking statements for any reason.
View original
content:https://www.prnewswire.com/news-releases/fresh2-group-ltd-announces-nasdaq-ticker-symbol-change-from-anpc-to-fres-301829770.html
SOURCE Fresh2 Group Limited